Tigermed Expands Clinical Trial Capabilities With Oracle Health

Tigermed Expands Clinical Trial Capabilities With Oracle Health
Sciences InForm 
Chinese Clinical Research Organization Expands Deployment, Joins
Oracle CRO Advantage Program to Grow Business in Local and Global
Markets 
REDWOOD SHORES, CA -- (Marketwire) -- 01/08/13 --  Oracle (NASDAQ:
ORCL) 
News Facts 


 
--  Hangzhou Tigermed Consulting Co., Ltd, a leading clinical contract
    research organization (CRO) in China, recently selected Oracle Health
    Sciences InForm to more efficiently develop, conduct and manage
    electronic data capture (EDC)-based clinical trials on behalf of its
    clients.
--  Being an existing user of Oracle Clinical for their paper trials,
    Tigermed selected Oracle Health Sciences InForm to extend its
    competitive edge in the local market and support international
    expansion with a trusted and highly scalable, leading clinical data
    management platform.
--  With its standardized feature sets, comprehensive data capture
    functionality and multi-language capabilities, Oracle Health Sciences
    InForm provides Tigermed with a robust solution to meet the needs of
    China's clinical trial sponsors -- while allowing for seamless
    expansion into the global marketplace.
--  Oracle Health Sciences InForm's comprehensive data review capabilities
    will enable Tigermed to gain better control over its data and generate
    efficiency and productivity gains in data management and remote
    monitoring.
--  Using Oracle Health Sciences InForm, Tigermed will be able to develop
    flexible source verification strategies that allow rapid changes to
    the source verification workload based on data quality.
--  In addition, Tigermed will be able to take advantage of Oracle Health
    Sciences Central Designer's centralized study design environment to
    accelerate trial development and increase trial efficiency.
--  To differentiate its business and gain a competitive advantage,
    Tigermed joined the Oracle CRO Advantage Program -- a program that
    provides a framework for driving CRO success with Oracle Health
    Sciences products through training, sales and marketing support and
    tools and regular communications on Oracle products and strategy.

  
Supporting Quotes 


 
--  "By adopting Oracl
e Health Sciences InForm, we will be positioned to
    support the growing number of clinical trials conducted in China, and
    their sponsors, with leading clinical data management capabilities,"
    said Wen Chen, vice president, Tigermed. "Further, with Oracle's
    training and support through the Oracle CRO Advantage Program, we can
    maximize our investment in Oracle Health Sciences solutions --
    securing the confidence of a growing number of clinical trial
    sponsors."
--  "With a heavy focus on growth, Tigermed requires a solution that will
    extend its clinical data management and EDC capabilities," said Neil
    de Crescenzo, senior vice president and general manager, Oracle Health
    Sciences. "Tigermed relies on Oracle Health Sciences' world-class
    solutions, including Oracle Health Sciences InForm and Oracle Health
    Sciences Central Designer, to enable rapid trial set up, data
    accuracy, clinical trial productivity and informed decision making --
    helping Tigermed to gain the trust of both local and global trial
    sponsors."

  
Supporting Resources 


 
--  Oracle in Health Sciences
--  Oracle Health Sciences InForm
--  Oracle Clinical
--  Oracle Health Sciences Central Designer
--  Follow Oracle Health Sciences on Twitter
--  Join the Oracle Health Sciences Community on Facebook
--  Oracle Health Sciences on YouTube

  
About Oracle 
 Oracle engineers hardware and software to work together
in the cloud and in your data center. For more information about
Oracle (NASDAQ: ORCL), visit www.oracle.com. 
About Oracle in Industries
 Oracle industry solutions leverage the
company's best-in-class portfolio of products to address complex
business processes relevant to health sciences, helping speed time to
market, reduce costs, and gain a competitive edge. 
Trademarks 
Oracle and Java are registered trademarks of Oracle and/or its
affiliates. Other names may be trademarks of their respective owners. 
About Tigermed
 Hangzhou Tigermed Consulting Co., Ltd is a leading
full service clinical stage Contract Research Organization (CRO) in
China. For more information about Tigermed (ChiNext 300347), visit
www.tigermed.net  
Contact Info 
Greg Lunsford
Oracle
+1.650.506.6523
greg.lunsford@oracle.com 
Mary Tobin
O'Keeffe & Company
+1.503.658.7396
mtobin@okco.com